Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors

Journal of Clinical Oncology

Volumn 26, Issue 15, 2008, Pages 2538-2543

  Barbot, Anne Claire ^a   Mussault, Pascale ^a   Ingrand, Pierre ^a   Tourani, Jean Marc ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LACTATE DEHYDROGENASE;

ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; ANOREXIA; ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; CONFUSION; DYSPNEA; EDEMA; FEMALE; HOSPITALIZATION; HUMAN; KARNOFSKY PERFORMANCE STATUS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS; ADULT; CLINICAL TRIAL; HEALTH SURVEY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PROSPECTIVE STUDY; RISK FACTOR; TIME;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 45149093742     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.9518     Document Type: Article

References (38)

1. Christakis NA, Lemont EB: Extent and determinants of error in doctors prognoses in terminally ill patients: Prospective cohort study. BMJ 320:469-472, 2000
2. Heyse-Moore LH, Johnson-Bell VE: Can doctors accurately predict the life expectancy of patients with terminal cancer? Palliat Med 1:165-166, 1987
3. Evans C, McCarthy M: Prognostic uncertainty in terminal care: Can the Karnofsky index help? Lancet 1:1204-1206, 1985
4. Maltoni M, Nanni O, Innocenti MP, et al: Clinical prediction of survival is more accurate than the Karnofsky Performance Status in estimating life span of terminally ill cancer patients. Eur J Cancer 30A:764-766, 1994
5. Glare P, Virik K, Jones M, et al: A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327:195-198, 2003
6. Viganò A, Dorgan M, Bruera E, et al: The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 86:170-176, 1999
7. Viganò A, Dorgan M, Buckingham J, et al: Survival prediction in terminal cancer patients: A systematic review of the medical literature. Palliat Med 14:363-374, 2000
8. Lamont EB, Christakis NA: Complexities in prognostication in advanced cancer. JAMA 290:98-104, 2003
9. Maltoni M, Nanni O, Pirovano M, et al: Successful validation of the palliative prognostic score in terminally ill cancer patients: Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 17:240-247, 1999
10. Morita T, Tsunoda J, Inoue S, et al: The palliative prognostic index: A scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 7:128-133, 1999
11. Glare P, Virik K: Independent prospective validation of the PaP Score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage 22:891-898, 2001
12. Morita T, Tsunoda J, Inoue S, et al: Improved accuracy of physicians survival prediction for terminally ill cancer patients using the Palliative Prognostic Index. Palliat Med 15:419-424, 2001
13. Caraceni A, Nanni O, Maltoni M, et al: Impact of delirium on the short term prognosis of advanced cancer patients: Italian Multicenter Study Group on Palliative Care. Cancer 89:1145-1149, 2000
14. Pirovano M, Maltoni M, Nanni O, et al: A new palliative prognostic score: A first step for the staging of terminally ill cancer patients. J Pain Symptom Manage 17:231-239, 1999
15. Maltoni M, Caraceni A, Brunelli C, et al: Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations-A study by the steering committee of the European Association for Palliative Care. J Clin Oncol 23:6240-6248, 2005
16. Earle CC, Neville BA, Landrum MB, et al: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321, 2004
17. Palmer P, Vinke J, Philip T, et al: Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol 3:475-480, 1992
18. Bachelot T, Ray-Coquard I, Catimel G, et al: Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials. Ann Oncol 11:151-156, 2000
19. Maltoni M, Pirovano M, Scarpi E, et al: Prediction of survival of patients' terminally ill cancer. Cancer 75:2613-2622, 1995
20. Rosenthal MA, Gebski VJ, Kefford RF, et al: Prediction of life-expectancy in hospice patients: Identification of novel prognostic factors. Palliat Med 7:199-204, 1993
21. Allard P, Dionne A, Potvin D: Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care 11:20-24, 1995
22. Bruera E, Miller MJ, Kuehn N, et al: Estimate of survival of patients admitted to a palliative care unit: A prospective study. J Pain Symptom Manage 7:82-86, 1992
23. Glare P: Clinical predictors of survival in advanced cancer. J Support Oncol 3:331-339, 2005
24. Morita T, Tsunoda J, Inoue S, et al: Contributing factors to physical symptoms in terminally ill cancer patients. J Pain Symptom Manage 18:338-346, 1999
25. Barber MD, Ross JA, Fearon KCH: Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35:106-110, 1999
26. Heyse-Moore LH, Ross V, Muline MA: How much of a problem is dyspnoea in advanced cancer? Palliat Med 5:20-25, 1991
27. Teunissen SC, de Graeff A, de Haes HC, et al: Prognostic significance of symptoms of hospitalised advanced cancer patients. Eur J Cancer 42:2510-2516, 2006
28. Cohen MH, Makuch R, Johnston-Early A, et al: Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep 65:187-195, 1981
29. Maltoni M, Pirovano M, Nanni O, et al: Biological indices predictive of survival in 519 Italian terminally ill cancer patients. J Pain Symptom Manage 13:1-9, 1997
30. Ventafridda V, De Conno F, Saita L, et al: Leucocyte-lymphocyte ratio as prognostic indicator of survival in cachectic cancer patients. Ann Oncol 2:196, 1991 (letter)
31. Goldwasser P, Feldman J: Association of serum albumin and mortality risk. J Clin Epidemiol 50:693-703, 1997
32. Herrmann FR, Safran C, Levkoff SE, et al: Serum albumin level on admission as predictor of death, length of stay, and readmission. Arch Intern Med 152:125-130, 1992
33. McMillan DC, Elahi MM, Setter N, et al: Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41:64-69, 2001
34. Elahi MM, McMillan DC, McArdle CS, et al: Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 48: 171-173, 2004
35. Maguire P: The will to live in the cancer patient, in Stoll BA (ed): Mind and Cancer Prognosis. Chichester, NY, John Wiley and Sons, 1979, pp 169-182
36. Chow E, Fung KW, Panzarella T, et al: A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 53:1291-1302, 2002
37. Kemeny N, Braun DW: Prognostic factors in advanced colorectal carcinoma: Importance of lactic dehydrogenase level, performance status, and white blood cell count. Am J Med 74:786-794, 1983
38. Geissbühler P, Mermillod B, Rapin CH: Elevated serum vitamin B12 associated with CRP as a predictive factor of mortality in palliative care patients: A prospective study over five years. J Pain Symptom Manage 20:93-103, 2000